German ministers have reacted angrily following reports US president Donald Trump offered a German medical company “large sums of money” for exclusive rights to a Covid-19 vaccine.
“Germany is not for sale,” economy minister Peter Altmaier told broadcaster ARD, reacting to a front page report in Welt am Sonntag newspaper headlined “Trump vs Berlin”.
The newspaper reported Trump offered $1bn to Tübingen-based biopharmaceutical company CureVac to secure the vaccine “only for the United States”.
The German government was reportedly offering its own financial incentives for the vaccine to stay in the country.
The report prompted fury in Berlin. “German researchers are taking a leading role in developing medication and vaccines as part of global cooperation networks,” foreign minister Heiko Maas told the Funke Mediengruppe research network. “We cannot allow a situation where others want to exclusively acquire the results of their research,” said Maas, of the centre-left SPD.
“International co-operation is important now, not national self-interest,” said Erwin Rüddel, a conservative lawmaker on the German parliament’s health committee.
The German health minister, Jens Spahn, said a takeover of CureVac by the Trump administration was “off the table”. CureVac would only develop vaccine “for the whole world”, Spahn said, “not for individual countries”.
Worldwide infections have grown to more than more than 86,000, according to the Johns Hopkins university tracker, while cases inside China stood at 80,860 as of Monday. Deaths outside China have risen to more than 3,241, while deaths in mainland China stand at 3,208 as of Monday.